VERTEX PHARMACEUTICALS INC / MA (VRTX) Operating margin 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) operating margin by fiscal year — reported operating income divided by reported revenue.
34.8%FY2025 · since FY2016: 0.6% → 34.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 34.8% | +36.9 pp |
| FY2024 | -2.1% | -40.9 pp |
| FY2023 | 38.8% | -9.4 pp |
| FY2022 | 48.2% | +11.5 pp |
| FY2021 | 36.7% | -9.3 pp |
| FY2020 | 46.0% | +17.3 pp |
| FY2019 | 28.8% | +7.9 pp |
| FY2018 | 20.8% | +15.9 pp |
| FY2017 | 5.0% | +4.4 pp |
| FY2016 | 0.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice